JP5300477B2 - 薬理活性物質の吸収性が改善された医薬組成物 - Google Patents
薬理活性物質の吸収性が改善された医薬組成物 Download PDFInfo
- Publication number
- JP5300477B2 JP5300477B2 JP2008527720A JP2008527720A JP5300477B2 JP 5300477 B2 JP5300477 B2 JP 5300477B2 JP 2008527720 A JP2008527720 A JP 2008527720A JP 2008527720 A JP2008527720 A JP 2008527720A JP 5300477 B2 JP5300477 B2 JP 5300477B2
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- component
- pharmacologically active
- fatty acid
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008527720A JP5300477B2 (ja) | 2006-08-01 | 2007-07-26 | 薬理活性物質の吸収性が改善された医薬組成物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006209863 | 2006-08-01 | ||
JP2006209863 | 2006-08-01 | ||
PCT/JP2007/064685 WO2008015959A1 (fr) | 2006-08-01 | 2007-07-26 | Composition pharmaceutique permettant une meilleure absorption d'une substance pharmacologiquement active |
JP2008527720A JP5300477B2 (ja) | 2006-08-01 | 2007-07-26 | 薬理活性物質の吸収性が改善された医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2008015959A1 JPWO2008015959A1 (ja) | 2009-12-24 |
JP5300477B2 true JP5300477B2 (ja) | 2013-09-25 |
Family
ID=38997138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008527720A Expired - Fee Related JP5300477B2 (ja) | 2006-08-01 | 2007-07-26 | 薬理活性物質の吸収性が改善された医薬組成物 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5300477B2 (zh) |
KR (1) | KR101390695B1 (zh) |
CN (1) | CN101495150B (zh) |
WO (1) | WO2008015959A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102139115B (zh) * | 2011-03-30 | 2012-12-05 | 天津红日药业股份有限公司 | 阿托伐他汀的环糊精包合物及其口服固体制剂的制备方法 |
CA2857430C (en) | 2011-12-14 | 2019-12-03 | Lts Lohmann Therapie-Systeme Ag | Wafer and capsule formulations with enhanced dissolution rates for fenofibrate |
CN104080450A (zh) * | 2012-01-05 | 2014-10-01 | 阿拉维制药公司 | 扎那米韦生物利用度增强的制剂 |
CN105012267A (zh) * | 2015-08-19 | 2015-11-04 | 海南科进生物制药有限公司 | 一种瑞巴派特片及其制备方法 |
CN105617353A (zh) * | 2016-01-04 | 2016-06-01 | 李志海 | 一种黏菌素口服给药组合物 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5372814A (en) * | 1976-12-03 | 1978-06-28 | Scherer Ltd R P | Pharmaceutical composition |
JPH06502143A (ja) * | 1990-10-19 | 1994-03-10 | プロヴァリス ユーケー リミテッド | 親油性薬剤用の2相放出配合物 |
JPH07196483A (ja) * | 1993-11-25 | 1995-08-01 | Taisho Pharmaceut Co Ltd | 経口吸収性を改善した製剤組成物 |
JPH07507565A (ja) * | 1992-10-02 | 1995-08-24 | ファイザー・インク. | 非イオン性表面活性剤を含有する医薬組成物 |
JPH10503750A (ja) * | 1994-03-16 | 1998-04-07 | アール. ピー. シェーラー リミテッド | 疎水性薬剤の投与システム |
JPH10231254A (ja) * | 1996-12-19 | 1998-09-02 | Dai Ichi Seiyaku Co Ltd | 経口吸収改善医薬用組成物 |
JP2001288117A (ja) * | 2000-04-05 | 2001-10-16 | Otsuka Pharmaceut Co Ltd | 医薬製剤用組成物 |
JP2002532539A (ja) * | 1998-12-18 | 2002-10-02 | アボット・ラボラトリーズ | 脂質調節剤を含む新規な製剤 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1240363A (zh) * | 1996-12-19 | 2000-01-05 | 第一制药株式会社 | 口服给药的药物组合物 |
-
2007
- 2007-07-26 KR KR1020097004307A patent/KR101390695B1/ko not_active IP Right Cessation
- 2007-07-26 JP JP2008527720A patent/JP5300477B2/ja not_active Expired - Fee Related
- 2007-07-26 WO PCT/JP2007/064685 patent/WO2008015959A1/ja active Application Filing
- 2007-07-26 CN CN2007800283846A patent/CN101495150B/zh not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5372814A (en) * | 1976-12-03 | 1978-06-28 | Scherer Ltd R P | Pharmaceutical composition |
JPH06502143A (ja) * | 1990-10-19 | 1994-03-10 | プロヴァリス ユーケー リミテッド | 親油性薬剤用の2相放出配合物 |
JPH07507565A (ja) * | 1992-10-02 | 1995-08-24 | ファイザー・インク. | 非イオン性表面活性剤を含有する医薬組成物 |
JPH07196483A (ja) * | 1993-11-25 | 1995-08-01 | Taisho Pharmaceut Co Ltd | 経口吸収性を改善した製剤組成物 |
JPH10503750A (ja) * | 1994-03-16 | 1998-04-07 | アール. ピー. シェーラー リミテッド | 疎水性薬剤の投与システム |
JPH10231254A (ja) * | 1996-12-19 | 1998-09-02 | Dai Ichi Seiyaku Co Ltd | 経口吸収改善医薬用組成物 |
JP2002532539A (ja) * | 1998-12-18 | 2002-10-02 | アボット・ラボラトリーズ | 脂質調節剤を含む新規な製剤 |
JP2001288117A (ja) * | 2000-04-05 | 2001-10-16 | Otsuka Pharmaceut Co Ltd | 医薬製剤用組成物 |
Also Published As
Publication number | Publication date |
---|---|
CN101495150A (zh) | 2009-07-29 |
KR20090038481A (ko) | 2009-04-20 |
CN101495150B (zh) | 2011-06-01 |
KR101390695B1 (ko) | 2014-04-30 |
WO2008015959A1 (fr) | 2008-02-07 |
JPWO2008015959A1 (ja) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5252926B2 (ja) | 薬物含有ワックスマトリックス粒子の製造方法、該方法に使用されるエクストルーダー、及びシロスタゾールを含有する徐放性製剤 | |
AU2007276874B2 (en) | Granular pharmaceutical compositions | |
JP2012116863A (ja) | 薬学的組成物における活性成分の改善された送達のための固体キャリア | |
US20080014257A1 (en) | Oral dosage forms | |
WO2007018943A2 (en) | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions | |
CN101170963A (zh) | 制备缓释液体制剂的组合物和方法 | |
JP5300477B2 (ja) | 薬理活性物質の吸収性が改善された医薬組成物 | |
CN103228654A (zh) | 作为JAK抑制剂的咪唑并[1,2-b]哒嗪以及咪唑并[4,5-b]吡啶衍生物 | |
KR20070089207A (ko) | 염기성 약물 또는 그의 염을 함유하는 매트릭스형 서방성 제제 및 그의 제조 방법 | |
JP2011057712A (ja) | アデノシンアナログの経口投与 | |
EP2164631A1 (en) | Modifying drug release in suspensions of ionic resin systems | |
US20220280645A1 (en) | Pharmaceutical Eutectic Salt Formation | |
KR20090117894A (ko) | 미립자 유성 현탁액을 포함하는 의약 조성물 | |
CN101340882B (zh) | 含有药物的蜡基质粒子的制造方法、用于该方法的挤出机、及含有西洛他唑的缓释制剂 | |
CN105395504B (zh) | 一种盐酸氟桂利嗪骨架缓释片及其制备方法 | |
WO2006117803A2 (en) | Transmucosal drug delivery systems | |
EP1952805B1 (en) | Tablet containing hydrogenated phospholipids | |
TW201343163A (zh) | 含匹伐他汀(pitavastatin)穩定配方的醫藥組合物 | |
KR101506626B1 (ko) | 아세브로필린 및 소수성 서방기제를 포함하는 서방형 약학 조성물 | |
WO2009006299A2 (en) | Multi-particulate systems | |
KR20170086053A (ko) | 디메틸 푸마르산염을 포함하는 제약학적 매트릭스 제제 | |
JP2020075924A (ja) | エルロチニブを有効成分とする医薬錠剤 | |
KR101506627B1 (ko) | 아세브로필린 및 친수성 서방기제를 포함하는 서방형 약학 조성물 | |
EP1803447B1 (en) | Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment | |
TW200944537A (en) | Formulations comprising a phosphoindole compound and one or more second active agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100723 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121204 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130201 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130226 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130426 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130528 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130618 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |